Arm

Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million

Retrieved on: 
Tuesday, April 2, 2024
Disease, Macular edema, NIU, Paratriathlon, Arm, Rule, Safety, Risk, Webcast, Inflammation, Patient, NEPTUNE, EDT, Master of Science, Haze, Prednisone, Visual acuity, Therapy, Sumitomo Pharma, Calendar, Share repurchase, JAK, Visual impairment, Physician, Hand, Pediatrics, Pharmaceutical industry

We are also pleased to announce our authorized share repurchase program, and our agreed repurchase of all shares owned by Sumitomo Pharma.

Key Points: 
  • We are also pleased to announce our authorized share repurchase program, and our agreed repurchase of all shares owned by Sumitomo Pharma.
  • The NEPTUNE study enrolled 26 subjects with active NIU who were randomized 2:1 to brepocitinib 45 mg once daily or brepocitinib 15 mg once daily.
  • All week 24 secondary efficacy endpoints, including haze grades, visual acuity, and macular thickness, were also positive and dose responsive.
  • The presentation and webcast details are also available under “Events & Presentations” in the Investors section of the Roivant website at https://investor.roivant.com/news-events/events.

ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System

Retrieved on: 
Tuesday, April 2, 2024
De novo, DPT, BCI, Arm, Paralysis, Evaluation, Doctor of Philosophy, Quality of life, Euronext, BDD, Annual report, Craig Hospital, Spinal cord, Safety, ARC, Food, Marketing, FDA, SCI, NCS, Movement, Hand, Medical device

EINDHOVEN, the Netherlands, April 02, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to improve or restore movement, function, and independence in people with spinal cord injury (SCI), today announces it has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System to restore function of the upper extremities after SCI.

Key Points: 
  • The submission marks an historic milestone for the Company in its mission to restore mobility and function for people with SCI.
  • Once cleared by the FDA, ARC-EX will be the first-ever spinal cord stimulation therapy to restore hand and arm function after SCI and the first commercial product for ONWARD Medical.
  • “We are delighted to be one step closer to bringing our breakthrough ARC-EX System to people living with SCI after submitting this De Novo application for regulatory clearance in the United States,” said ONWARD Medical CEO Dave Marver.
  • The ARC-EX System was previously awarded FDA Breakthrough Device Designation (BDD) for upper limb function, which provided prioritized FDA review, the opportunity to interact with FDA experts, and the potential for additional reimbursement.

Canon Adds Powerful Scanning Capabilities to its imagePROGRAF Printer Portfolio with Two WideTEK® Scanners from Image Access

Retrieved on: 
Thursday, March 28, 2024
FTP, GP, Arm, Portrait, Running, Photography, Software, Linux, USB, System, CIS, CCD, MFP, CAD, Television

The Image Access WideTEK® 36CL CIS scanner is ideal for scanning text documents and CAD drawings up to 36” wide, and the Image Access WideTEK® 48 CCD scanner designed for scanning artwork, photographs, and related images up to 48” wide.

Key Points: 
  • The Image Access WideTEK® 36CL CIS scanner is ideal for scanning text documents and CAD drawings up to 36” wide, and the Image Access WideTEK® 48 CCD scanner designed for scanning artwork, photographs, and related images up to 48” wide.
  • The WideTEK® 36CL produces extraordinarily sharp images, with high color accuracy, even superior to competing CCD scanners on the market today.
  • The WideTEK® 48 CCD scanner can digitize graphics documents up to 48 inches wide at astonishingly fast speeds.
  • These scanners are an addition to Canon’s current lineup of imagePROGRAF, ColorWave and PlotWave multifunction technical document solutions.

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

Retrieved on: 
Thursday, March 28, 2024
FSA, U.S. FDA, Arm, Heroin, Risk, Education, Pharmacy, School, Naloxone, Policy, EBS, Flexible, House, Drug, OTC, CDC, Restaurant, Medicaid, National Safety Council, AED, HSA, FDA, Emergent BioSolutions, NSC, Medicine, Fentanyl, Pharmaceutical industry

Emergent and other stakeholders in the fight must continue raising awareness about the availability of products like NARCAN® Nasal Spray, reducing stigma and further improving access for all Americans.

Key Points: 
  • Emergent and other stakeholders in the fight must continue raising awareness about the availability of products like NARCAN® Nasal Spray, reducing stigma and further improving access for all Americans.
  • Since the OTC launch, NARCAN® Nasal Spray can be purchased at more than 32,000 mass drug, grocery, online retailers and e-commerce sites.
  • Emergent is working with retail partners to make it easy to find and access, however each retailer ultimately determines in-store product placement.
  • “That’s why we remain committed to increasing awareness of NARCAN® Nasal Spray availability.

SEMCAP Buys Into the Next Phase of ALOHA's Growth, Investing Nearly $70 Million For a Significant Minority Stake

Retrieved on: 
Tuesday, March 26, 2024
Health, Arm, Growth, Nutrition, Acceleration, Partnership, Snack, Education, Kate Storey, ALOHA, General Mills, Food, B Corporation (certification), Management

ALOHA employees and management will retain a significant stake in the company, maintaining the company’s status as an independently operated entity.

Key Points: 
  • ALOHA employees and management will retain a significant stake in the company, maintaining the company’s status as an independently operated entity.
  • Through this strategic partnership, ALOHA will add SEMCAP's operating experience and network to bolster its business’s continuous growth.
  • Between 2020 and 2023, ALOHA achieved nearly 500% growth while achieving significant profitability and positive cash flow.
  • The company is poised to maintain high double-digit topline growth throughout the course of this year and beyond.

Ambiq Apollo510 Delivers 30x Power Efficiency Improvement to Unleash Endpoint AI

Retrieved on: 
Tuesday, March 26, 2024
Cortex, Arm, Health, Speech, Socs, SRAM, GM, GPU, VR, Hardware, Acceleration, Intelligence, Agriculture, Internet of things, Business, SVP, MCU, AI, Software, Human, TEE, Memory, ARM architecture family, Macs, TCM, OTP, SPOT, PUF, Family, MIP, NVM, Consumer electronics

AUSTIN, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Ambiq, a technology leader in exceptionally energy-efficient semiconductors for IoT devices, is introducing the new Apollo510, the first member of the Apollo5 SoC family, which is uniquely positioned to kickstart the age of truly ubiquitous, practical, and meaningful AI.

Key Points: 
  • The Apollo510 achieves up to 10x better latency while reducing energy consumption by around 2x, compared to Ambiq's previous power efficiency leader, the Apollo4.
  • With more than 30x energy improvement, the Apollo510 is capable of running a vast majority of today's endpoint AI calculations, including low-power sensor monitoring, always-on voice commands, telco-quality audio enhancement, and more.
  • Apollo510 contains everything needed for driving intelligent systems: ultra-efficient compute, expansive on-chip memories, high-bandwidth interfaces to off-chip memories, and security.
  • IoT endpoint device manufacturers can expect unrivaled power efficiency to develop more capable devices that process AI/ML functions better than before.

Renesas Introduces New Entry-Level RA0 MCU Series with Best-in-Class Power Consumption

Retrieved on: 
Tuesday, April 9, 2024
Software, Hardware, Data Management, Consumer Electronics, IOT (Internet of Things), Technology, Other Manufacturing, Construction & Property, Artificial Intelligence, Semiconductor, Security, Building Systems, Manufacturing, Combination, Arm, Automation, Temperature, M23, Environment, Internet of things, Business, LQFP, Embedded, Library, Internet, BOM, MCU, Renesas Electronics, TRNG, Family, QFN, HOCO, Ecosystem, BSP, Series, Multimedia, HMI, FSP, AES, Building, Mobile phone

Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today introduced the RA0 microcontroller (MCU) Series based on the Arm® Cortex®-M23 processor.

Key Points: 
  • Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today introduced the RA0 microcontroller (MCU) Series based on the Arm® Cortex®-M23 processor.
  • The new, low-cost RA0 devices offer the industry’s lowest overall power consumption for general purpose 32-bit MCUs.
  • In addition, Renesas offers a Software Standby mode in the new MCUs that reduces power consumption by a further 99 percent to a miniscule 0.2 µA.
  • Renesas is now shipping the first group in the RA0 Series, the RA0E1 Group.

Ashling Announces Support for Altera’s Agilex™ 5 FPGA Family in their RiscFree™ SDK and Toolchain

Retrieved on: 
Monday, April 8, 2024
Software, Technology, Semiconductor, Apps, Applications, Cortex, Arm, Intel, Socs, A55, DSP, Linux, Partnership, Nios, ARM Cortex-A53, Quartus, SDK, Family, FPGA, Agilex, Video game

The Agilex 5 FPGA family with its dual-core A55 and dual-core A76 Arm processors, is optimized for high performance with lower power consumption.

Key Points: 
  • The Agilex 5 FPGA family with its dual-core A55 and dual-core A76 Arm processors, is optimized for high performance with lower power consumption.
  • It features enhanced DSP capabilities and an AI Tensor block, positioning it as a mid-range FPGA solution ideal for a wide range of applications.
  • Hugh O’Keeffe, CEO of Ashling, expressed enthusiasm about the ongoing collaboration: "As one of the premier Arm and RISC-V toolchain providers, we are delighted to extend our partnership with Altera by integrating support for the Agilex 5 FPGA family into our RiscFree toolchain.
  • As the embedded tools market continues to evolve, Ashling's RiscFree SDK and Toolchain stand out for their ease of use, broad functionality, and modular architecture.

Octavo Systems Unveils the OSD32MP2 Series: Revolutionizing System Design in the Electronics Industry

Retrieved on: 
Tuesday, April 9, 2024
Cortex, SIP, Arm, Automation, GPU, Memory, DDR4, Electronics, Vulkan, API, ARM architecture family, Family, STMicroelectronics, EEPROM, Mobile phone

NUREMBERG, Germany, April 9, 2024 /PRNewswire/ -- Octavo Systems , a leader in system integration technology, proudly announces the launch of its OSD32MP2 family , featuring two innovative System-in-Package (SiP) modules: the OSD32MP2 and OSD32MP2-PM .

Key Points: 
  • NUREMBERG, Germany, April 9, 2024 /PRNewswire/ -- Octavo Systems , a leader in system integration technology, proudly announces the launch of its OSD32MP2 family , featuring two innovative System-in-Package (SiP) modules: the OSD32MP2 and OSD32MP2-PM .
  • The OSD32MP2 family caters to a diverse range of applications, from industrial automation to consumer electronics, offering unparalleled processing power, connectivity, and security features.
  • "Octavo Systems is committed to empowering electronics design engineers by simplifying the complexities of modern electronic design," said Harley Walsh, President of Octavo Systems.
  • For additional information, including detailed specifications and ordering details, please visit https://octavosystems.com or contact Octavo Systems at [email protected] .

Alif Semiconductor Announces World's First BLE and Matter Wireless Microcontroller to Feature Neural Co-Processor for AI/ML Workloads

Retrieved on: 
Tuesday, April 9, 2024
Cortex, Arm, LPA, BLE, Machine learning, Logic, LC3, Algorithm, DSP, HPA, WLCSP, Acceleration, Memory, Business, ARM Cortex-M, MCU, AI accelerator, Bluetooth Low Energy, Spacecraft, Senior, TWS, Architecture, Radio, DAC, NPU, TCM, GOPS, Family, MVE, Artificial intelligence, EEMBC, Lethargy, Video game

PLEASANTON, Calif., April 9, 2024 /PRNewswire/ -- Alif Semiconductor®, a leading global supplier of secure, connected, power efficient Artificial Intelligence and Machine Learning (AI/ML) microcontrollers (MCUs) and fusion processors, today announced the launch of the BallettoTM family, the world's first Bluetooth® Low Energy (BLE) wireless microcontroller to feature hardware optimization for AI/ML workloads.

Key Points: 
  • The Balletto family offers particularly strong performance in audio and sensor functions thanks to its excellent DSP and AI/ML capabilities and large on-die memory.
  • Neural network processing performance is up to 15x better than a Cortex-M4 processor can achieve.
  • Balletto includes the state-of-the-art multi-layered security fabric first introduced in Alif Semiconductors' Ensemble family of MCUs and fusion processors.
  • "Alif Semiconductor's Balletto family is targeting BLE challenges faced by the wireless audio and smart home industry today with a platform adapted to high bit-rate audio and the Matter ecosystem," said Reza Kazerounian, President and Co-Founder of Alif Semiconductor.